Clinical trial
Monocentric Study, Prospective, Open and Non Controlled for to Evaluate the Effectiveness, and Tolerability the Safety of Association of Clindamycin Phosphate 1.2% and Tretinoin 0,025% in the Treatment of Acne Vulgaris Mild to Moderate, When Used Once Daily for 12 Weeks.
NCT00838812 is registered in ClinicalTrials.gov with Igefarma Laboratorios S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monocentric Study, Prospective, Open and Non Controlled for to Evaluate the Effectiveness, and Tolerability the Safety of Association of Clindamycin Phosphate 1.2% and Tretinoin 0,025% in the Treatment of Acne Vulgaris Mild to Moderate, When Used Once Daily for 12 Weeks.
- Lead sponsor
- Igefarma Laboratorios S.A.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2009
- Completion date
- April 30, 2010
- Enrollment
- 154 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.